A New Paradigm in Permanent Contraception

Our Mission

Empower women with improved means to manage their reproductive health by providing access to patient-focused, safe, non-surgical, reliable permanent contraception.


In the US per annum


women no longer intend to have children


of annual 6 Million pregnancies are unintended


women use non permanent birth control long term


endometrial ablations annually


women undergo tubal ligation each year


of women surveyed would consider AltaSeal®

Permanent Contraception
Current standard of care: Tubal Ligation

What is Tubal Ligation?

Tubal ligation is a type of permanent birth control where the fallopian tubes are cut, tied or blocked to permanently prevent pregnancy.

Around the world, circa 220 million women are currently relying on permanent contraception via surgical tubal ligation to avoid pregnancy.

Our Focus

For Women: To provide permanent contraception that is office-based and easily-accessible through a simple, effective, non-surgical procedure. 

For Health Service Providers: To provide an ambulatory out-patient procedure so that best-in-class care can be provided.


  • Office based procedure.
  • Permanent biocompatible metal implant.
  • Atraumatic & easy-to-use.
  • Placed in the fallopian tubes using a hysteroscope.
  • Implant blocks the fallopian tube and prevents pregnancy.
Currently no Hysteroscopic Permanent Contraceptive Device on the Market.
"The majority of women wearing the AltaSeal® have expressed year after year their satisfaction with wearing the device and voiced how convenient the procedure was, allowing them to quickly return to their normal activities "

Caroline Collins

Clinical Research Lead Nurse

News and Upcoming Events

HIHI femtech call winner 2023

AltaScience announced as HIHI femtech call 2023 winner 

 LSI Emerging Medtech Summit

AltaScience CEO recently presented at the LSI Emerging Medtech Summit